{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:12:15Z","timestamp":1790914335769,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.dld.2004.07.004","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T02:13:35Z","timestamp":1093572815000},"page":"703-711","source":"Crossref","is-referenced-by-count":19,"title":["Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?"],"prefix":"10.1016","volume":"36","author":[{"given":"G.","family":"Missale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2004.07.004_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"2","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.dld.2004.07.004_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib3","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dld.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0016-5085(93)90430-K","article-title":"T-lymphocyte response to hepatitis C virus in different clinical courses of infection","volume":"24","author":"Bottarelli","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"Missale","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/gut.44.3.424","article-title":"Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients with hepatitis C viremia","volume":"44","author":"Cramp","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/315450","article-title":"Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C","volume":"181","author":"Gruener","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.dld.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib12","first-page":"790","article-title":"T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia","volume":"1","author":"Lechmann","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhep.2001.21162","article-title":"Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection","volume":"33","author":"Chang","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.510250233","article-title":"Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity","volume":"3","author":"Tsai","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.159.2.1012","article-title":"CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes","volume":"159","author":"Woitas","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/gast.2001.27024","article-title":"Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response","volume":"121","author":"Kamal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib17","first-page":"115","article-title":"Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus","volume":"3","author":"Zibert","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib18","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dld.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses","volume":"188","author":"Kalams","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.193.3.297","article-title":"Impairment of CD4(+) T-cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants","volume":"193","author":"Ciurea","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis C virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib22","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI8229","article-title":"Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection","volume":"3","author":"Rentenaar","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JVI.73.4.3317-3325.1999","article-title":"Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus","volume":"73","author":"Major","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib25","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/JVI.72.4.2589-2599.1998","article-title":"Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles","volume":"72","author":"Bassett","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection","volume":"33","author":"Bassett","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib28","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/383279","article-title":"Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort","volume":"189","author":"Post","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.dld.2004.07.004_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0042-6822(03)00461-6","article-title":"Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees","volume":"314","author":"Shata","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.dld.2004.07.004_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/JVI.76.24.12423-12434.2002","article-title":"Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C","volume":"76","author":"Urbani","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib31","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1128\/JVI.75.12.5550-5558.2001","article-title":"Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus","volume":"75","author":"Gruener","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib33","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/JVI.68.3.1494-1500.1994","article-title":"Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses","volume":"68","author":"Shimizu","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(01)00180-2","article-title":"Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?","volume":"52","author":"Mondelli","year":"2001","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.dld.2004.07.004_bib36","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1073\/pnas.92.7.2755","article-title":"Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant","volume":"92","author":"Weiner","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dld.2004.07.004_bib37","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.162.7.4177","article-title":"Mutations in immunodominant T-cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T-cell recognition","volume":"162","author":"Wang","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","article-title":"The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes","volume":"15","author":"Erickson","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.dld.2004.07.004_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1084\/jem.181.3.1047","article-title":"The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis","volume":"181","author":"Rehermann","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib40","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"20","author":"Chang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.07.004_bib41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4049\/jimmunol.163.2.650","article-title":"Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells","volume":"163","author":"Frasca","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0198-8859(03)00070-3","article-title":"Modulation of the peripheral T-cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response","volume":"64","author":"Wang","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib43","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","article-title":"Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection","volume":"69","author":"Wedemeyer","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib45","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1084\/jem.193.5.F19","article-title":"Assessing CD8 T-cell number and dysfunction in the presence of antigen","volume":"193","author":"Welsh","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.162.2.931","article-title":"Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence","volume":"162","author":"Large","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1172\/JCI10323","article-title":"Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation","volume":"26","author":"Kittlesen","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.07.004_bib48","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.4049\/jimmunol.162.9.5584","article-title":"Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals","volume":"162","author":"Kanto","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2001.21212","article-title":"Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection","volume":"120","author":"Bain","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib50","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1182\/blood.V97.10.3171","article-title":"Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection","volume":"97","author":"Auffermann-Gretzinger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.dld.2004.07.004_bib51","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","article-title":"Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells","volume":"178","author":"Brinkmann","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib52","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0168-8278(96)80225-X","article-title":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study","volume":"25","author":"Dusheiko","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.dld.2004.07.004_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","article-title":"Ribavirin polarizes human T-cell responses towards a Type 1 cytokine profile","volume":"30","author":"Tam","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.dld.2004.07.004_bib55","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0168-8278(98)80146-3","article-title":"The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome","volume":"29","author":"Lohr","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.dld.2004.07.004_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510260337","article-title":"Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients","volume":"26","author":"Missale","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/jhep.2002.35344","article-title":"The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection","volume":"36","author":"Barnes","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib58","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/gast.2002.36045","article-title":"Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C","volume":"123","author":"Kamal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/eji.200324540","article-title":"Subversion of effector CD8+ T-cell differentiation in acute hepatitis C virus infection: the role of the virus","volume":"34","author":"Accapezzato","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib60","doi-asserted-by":"crossref","first-page":"18877","DOI":"10.1074\/jbc.M300185200","article-title":"The hepatitis C virus core protein modulates T-cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations","volume":"278","author":"Bergqvist","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dld.2004.07.004_bib61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/viro.2000.0694","article-title":"Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages","volume":"279","author":"Lee","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.dld.2004.07.004_bib62","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.4049\/jimmunol.167.9.5264","article-title":"Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway","volume":"167","author":"Yao","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib63","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1086\/375350","article-title":"Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection","volume":"187","author":"Goutagny","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.dld.2004.07.004_bib64","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1128\/JVI.76.10.5062-5070.2002","article-title":"Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins","author":"Sarobe","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib65","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/eji.200324251","article-title":"Hepatitis virus non-structural protein 4 suppresses Th1 responses by stimulating IL-2 production from monocytes","volume":"33","author":"Brady","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib66","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.170.11.5615","article-title":"Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation","volume":"170","author":"Dolganiuc","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib67","first-page":"226","article-title":"Presence of functional dendritic cells in patients chronically infected with hepatitis C virus","volume":"23","author":"Longman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.dld.2004.07.004_bib68","doi-asserted-by":"crossref","first-page":"11644","DOI":"10.1128\/JVI.77.21.11644-11650.2003","article-title":"Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells","volume":"77","author":"Tardif","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib69","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1128\/JVI.77.14.7843-7855.2003","article-title":"Nonstructural protein precursor NS4A\/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus","volume":"77","author":"Konan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib70","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1128\/JVI.77.15.8299-8309.2003","article-title":"Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity","volume":"77","author":"Herzer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib71","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response in hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dld.2004.07.004_bib72","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1073\/pnas.062055699","article-title":"Regulation of PKR and IRF-1 during hepatitis C virus RNA replication","volume":"99","author":"Pflugheber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dld.2004.07.004_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural A protein","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.dld.2004.07.004_bib74","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1128\/JVI.73.8.6506-6516.1999","article-title":"Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase","volume":"73","author":"Gale","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon\u2013inducible protein kinase PKR by HCV E2 protein","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib77","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib78","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.73.10.8469-8475.1999","article-title":"Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway","volume":"73","author":"Heim","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib79","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0016-5085(03)00290-7","article-title":"Expression of hepatitis C virus proteins inhibits interferon \u03b1 signaling in the liver of transgenic mice","volume":"11","author":"Blindenbacher","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.07.004_bib80","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510310316","article-title":"Activation of nuclear factor kappa B in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis","volume":"31","author":"Tai","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib81","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.73.6.4713-4720.1999","article-title":"Hepatitis virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-\u03baB activation","volume":"73","author":"Marusawa","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.cdd.4401119","article-title":"Apoptosis in hepatitis C virus infection","volume":"2","author":"Bantel","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.dld.2004.07.004_bib83","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.1840190606","article-title":"Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C","volume":"19","author":"Hiramatsu","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib84","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.510250334","article-title":"Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection","volume":"3","author":"Hayashi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2004.07.004_bib85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/bbrc.1994.2483","article-title":"Role of Fas ligand in apoptosis induced by hepatitis C virus infection","volume":"204","author":"Mita","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.dld.2004.07.004_bib86","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2893.2001.00316.x","article-title":"Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection","volume":"8","author":"Pianko","year":"2001","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.dld.2004.07.004_bib87","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1128\/JVI.78.4.2152-2157.2004","article-title":"Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction","volume":"78","author":"Gremion","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.dld.2004.07.004_bib88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.179.3.841","article-title":"Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis","volume":"179","author":"Gonzalez-Amaro","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib89","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.07.004_bib90","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.4049\/jimmunol.158.11.5283","article-title":"Perforin, Fas\/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL","volume":"158","author":"Ando","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib91","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.1996.0644","article-title":"Suppression of apoptotic cell death by hepatitis C virus core protein","volume":"226","author":"Ray","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.dld.2004.07.004_bib92","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1074\/jbc.273.4.2256","article-title":"Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein","volume":"273","author":"Ray","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dld.2004.07.004_bib93","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1074\/jbc.M010137200","article-title":"Inhibition of cytochrome C release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins","volume":"276","author":"Machida","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dld.2004.07.004_bib94","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1093\/emboj\/17.23.6888","article-title":"Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling","volume":"17","author":"Balachandran","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.dld.2004.07.004_bib95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1074-7613(00)00014-5","article-title":"Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection","volume":"13","author":"Balachandran","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.dld.2004.07.004_bib96","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.dld.2004.07.004_bib97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20011124","article-title":"Inhibition of natural killer cells through the engagement of CD81 by the major hepatitis C virus envelope protein","volume":"195","author":"Crotta","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20011145","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions","volume":"195","author":"Tseng","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.dld.2004.07.004_bib99","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells","volume":"31","author":"Wack","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib100","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4049\/jimmunol.170.3.1249","article-title":"Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection","volume":"170","author":"Jinushi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.dld.2004.07.004_bib101","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0168-8278(02)00308-2","article-title":"The challenge of developing a vaccine against hepatitis C virus","volume":"37","author":"Forns","year":"2002","journal-title":"J. Hepatol."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804002932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804002932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T07:20:22Z","timestamp":1682752822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865804002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1590865804002932"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2004.07.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}